The cannabinoid 1-receptor silent antagonist O-2050 attenuates preference for high-fat diet and activated astrocytes in mice

Journal of Pharmacological Sciences

Volumn 112, Issue 3, 2010, Pages 369-372

  Higuchi, Sei ^a   Irie, Keiichi ^a,b   Mishima, Shohei ^a   Araki, Maiko ^a   Ohji, Makiko ^a   Shirakawa, Atsunori ^a   Akitake, Yoshiharu ^a,b   Matsuyama, Kiyoshi ^c   Mishima, Kenji ^c   Mishima, Kenichi ^a,b   Iwasaki, Katsunori ^a,b   Fujiwara, Michihiro ^a  

^a Faculty of Science   (Japan)

^b Advanced Materials Institute   (Japan)

^c FUKUOKA UNIVERSITY   (Japan)

Author keywords

Astrocyte; Endocannabinoid; Preference for high fat diet

Indexed keywords

6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR ANTAGONIST; ENDOCANNABINOID; GLIAL FIBRILLARY ACIDIC PROTEIN; O 2050; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL ACTIVATION; CONTROLLED STUDY; DIETARY INTAKE; DRUG MECHANISM; DRUG PROTEIN BINDING; FOOD PREFERENCE; HYPOTHALAMUS; LIPID DIET; MALE; MOUSE; NONHUMAN; PLACE PREFERENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 77950647242     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.09326SC     Document Type: Article

References (15)

1. Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, et al. 2-arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun. 1995; 215:89-97.
2. Cota D, Tschop MH, Horvath TL, Levine AS. Cannabinoids opioids and eating behavior: the molecular face of hedonism? Brain Res Rev. 2006;51:85-107.
3. Fujiwara M, Egashira N. New perspectives in the studies on endocannabinoid and cannabis: abnormal behaviors associate with CB1 cannabinoid receptor and development of therapeutic application. J Pharmacol Sci. 2004;96:362-366.
4. 9-tetrahydrocannabinol in rats. J Pharmacol Sci. 2001;87:297-308.
5. Marzo V Di, Cote M, Matias I, Lemieux I, Arsenault BJ, Cartier A, et al. Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors. Diabetologia. 2009;52:213-217.
6. Aguado T, Palazuelos J, Monory K, Stella N, Cravatt B, Lutz B, et al. The endocannabinoid system promotes astroglia differentiation by acting on neural progenitor cells. J Neurosci. 2006;26: 1551-1561.
7. Navarrete M, Araque A. Endocannabinoids mediate neuron-astrocyte communication. Neuron. 2008;57:883-893.
8. Narita M, Suzuki M, Kuzumaki N, Miyatake M, Suzuki T. Implication of astrocytes in the development of drug dependence. Ann N Y Acad Sci. 2008;1141:96-104.
9. Hsuchou H, He Y, Kastin AJ, Tu H, Markadakis EN, Rogers RC, et al. Obesity induces functional astrocytic leptin receptors in hypothalamus. Brain. 2009;132:889-902.
10. Hayakawa K, Mishima K, Nozako M, Hazekawa M, Mishima S, Fujioka M, et al. Delayed treatment with minocycline improves neurological impairment via activated microglia expressing high-mobility group box1 inhibiting mechanism. Stroke. 2008; 39:951-958.
11. Spyraki C, Fibiger HC, Phillips AG. Attenuation by haloperidol of preference conditioning using food reinforcement. Phychopharmacology (Berl). 1982;77:379-382.
12. Suzuki T, Mori T, Tsuji M, Nomura M, Onodera K. Evaluation of the histamine H1-antagonist-induced place preference in rats. J Pharmacol Sci. 1999;81:332-338.
13. Takeda M, Sawano S, Imaizumi M, Fushiki T. Preference for corn oil in olfactory-blocked mice in the conditioned place preference test and the two-bottle choice test. Life Sci. 2001;69: 847-854.
14. South T, Deng C, Huang XF. AM 251 and beta-Funaltrexamine reduce fat intake in a fat-preferring strain of mouse. Behav Brain Res. 2007;181:153-157.
15. Kirkham TC, Williams CM, Fezza F, Marzo V Di. Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoylglycerol. Br J Pharmacol. 2002;136:550-557.